CME Group Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
CME Group wird ein jährliches Gewinn- und Umsatzwachstum von 3.5% bzw. 4.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 3.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12.9% betragen.
Wichtige Informationen
4.1%
Wachstumsrate der Gewinne
3.9%
EPS-Wachstumsrate
Capital Markets Gewinnwachstum | 14.0% |
Wachstumsrate der Einnahmen | 4.5% |
Zukünftige Eigenkapitalrendite | 12.9% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 25 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
Jun 05Looking For (Special) Dividends? CME Group Remains One Of My Best Ideas In Finance
May 25CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
May 21Gunning For CME's Golden Goose
May 01Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results
Apr 26CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty
Apr 15CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates
Mar 27CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
Mar 05CME Group Is One Of My Favorite High-Yielding Stocks Today
Feb 29CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15
Feb 20CME Group: Buying 'The House' Proves A Winning Strategy
Feb 14CME Group: Uncertainty In The World Equals Higher Revenue Growth
Feb 04Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely
Dec 27Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors
Nov 14We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation
Apr 28CME Group (NASDAQ:CME) Is Paying Out A Larger Dividend Than Last Year
Dec 15CME Group ADV climbs 21% Y/Y to 6.1M in Q3
Oct 11CME Group Is The Perfect Dividend Stock To Buy While It's Cheap
Sep 30CME Group launches ethereum options ahead of this week's blockchain Merge
Sep 12With EPS Growth And More, CME Group (NASDAQ:CME) Makes An Interesting Case
Sep 08CME Group proposes converting eurodollar futures, options contracts to SOFR
Sep 06CME Group launches bitcoin Euro and ether Euro futures
Aug 29CME Group set to launch ether futures options in September
Aug 18Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 6,465 | 3,656 | 4,031 | 4,163 | 8 |
12/31/2025 | 6,114 | 3,455 | 3,772 | 3,936 | 14 |
12/31/2024 | 5,919 | 3,341 | 3,850 | 4,016 | 14 |
3/31/2024 | 5,616 | 3,157 | 3,363 | 3,444 | N/A |
12/31/2023 | 5,569 | 3,186 | 3,377 | 3,454 | N/A |
9/30/2023 | 5,338 | 3,011 | 3,311 | 3,391 | N/A |
6/30/2023 | 5,228 | 2,942 | 3,108 | 3,192 | N/A |
3/31/2023 | 5,104 | 2,828 | 3,078 | 3,159 | N/A |
12/31/2022 | 5,009 | 2,657 | 2,966 | 3,056 | N/A |
9/30/2022 | 4,833 | 2,633 | 2,650 | 2,743 | N/A |
6/30/2022 | 4,715 | 2,889 | 2,616 | 2,717 | N/A |
3/31/2022 | 4,657 | 2,745 | 2,477 | 2,599 | N/A |
12/31/2021 | 4,690 | 2,617 | 2,275 | 2,402 | N/A |
9/30/2021 | 4,630 | 2,435 | 2,225 | 2,394 | N/A |
6/30/2021 | 4,600 | 1,920 | 1,888 | 2,074 | N/A |
3/31/2021 | 4,603 | 1,913 | 2,378 | 2,561 | N/A |
12/31/2020 | 4,884 | 2,105 | 2,518 | 2,716 | N/A |
9/30/2020 | 4,911 | 2,151 | 2,581 | 2,775 | N/A |
6/30/2020 | 5,109 | 2,375 | 3,071 | 3,274 | N/A |
3/31/2020 | 5,200 | 2,386 | 2,521 | 2,761 | N/A |
12/31/2019 | 4,868 | 2,117 | 2,427 | 2,673 | N/A |
9/30/2019 | 4,959 | 2,033 | 2,229 | 2,464 | N/A |
6/30/2019 | 4,588 | 1,808 | 2,027 | 2,236 | N/A |
3/31/2019 | 4,377 | 1,860 | 2,137 | 2,285 | N/A |
12/31/2018 | 4,309 | 1,962 | 2,324 | 2,441 | N/A |
9/30/2018 | 3,973 | 4,516 | 2,301 | 2,391 | N/A |
6/30/2018 | 3,959 | 4,413 | 2,242 | 2,316 | N/A |
3/31/2018 | 3,824 | 4,262 | 1,977 | 2,057 | N/A |
12/31/2017 | 3,645 | 4,063 | N/A | 1,751 | N/A |
9/30/2017 | 3,658 | 1,498 | N/A | 1,801 | N/A |
6/30/2017 | 3,609 | 1,662 | N/A | 1,773 | N/A |
3/31/2017 | 3,590 | 1,566 | N/A | 1,732 | N/A |
12/31/2016 | 3,595 | 1,534 | N/A | 1,732 | N/A |
9/30/2016 | 3,496 | 1,452 | N/A | 1,607 | N/A |
6/30/2016 | 3,505 | 1,340 | N/A | 1,591 | N/A |
3/31/2016 | 3,418 | 1,284 | N/A | 1,626 | N/A |
12/31/2015 | 3,327 | 1,247 | N/A | 1,533 | N/A |
9/30/2015 | 3,354 | 1,262 | N/A | 1,644 | N/A |
6/30/2015 | 3,266 | 1,192 | N/A | 1,414 | N/A |
3/31/2015 | 3,178 | 1,191 | N/A | 1,327 | N/A |
12/31/2014 | 3,113 | 1,127 | N/A | 1,291 | N/A |
9/30/2014 | 2,958 | 1,014 | N/A | 1,171 | N/A |
6/30/2014 | 2,911 | 960 | N/A | 1,066 | N/A |
3/31/2014 | 2,990 | 1,008 | N/A | 1,268 | N/A |
12/31/2013 | 2,931 | 977 | N/A | 1,281 | N/A |
9/30/2013 | 2,905 | 951 | N/A | 1,221 | N/A |
6/30/2013 | 2,874 | 932 | N/A | 1,331 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: CMEDas prognostizierte Gewinnwachstum (3.5% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: CMEDie Erträge des Unternehmens (3.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.8% pro Jahr).
Hohe Wachstumserträge: CMEDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: CMEDie Einnahmen des Unternehmens (4.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.6% pro Jahr).
Hohe Wachstumseinnahmen: CMEDie Einnahmen des Unternehmens (4.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: CMEDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12.9%).